Home LiteratureArticle Details
PMID: 11217892 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Small variations in multiple parameters account for wide variations in HIV-1 set-points: a novel modelling approach.

Proceedings. Biological sciences ·Vol. 268 ·No. 1464 ·2001-02-07 ·Pages 235-42

Müller V, Marée AF, De Boer RJ

Abstract

Steady-state levels of HIV-1 viraemia in the plasma vary more than a 1,000-fold between HIV-positive patients and are thought to be influenced by several different host and viral factors such as host target cell availability, host anti-HIV immune response and the virulence of the virus. Previous mathematical models have taken the form of classical ecological food-chain models and are unable to account for this multifactorial nature of the disease. These models suggest that the steady-state viral load (i.e. the set-point) is determined by immune response parameters only. We have devised a generalized consensus model in which the conventional parameters are replaced by so-called 'process functions'. This very general approach yields results that are insensitive to the precise form of the mathematical model. Here we applied the approach to HIV-1 infections by estimating the steady-state values of several process functions from published patient data. Importantly, these estimates are generic because they are independent of the precise form of the underlying processes. We recorded the variation in the estimated steady-state values of the process functions in a group of HIV-1 patients. We developed a novel model by providing explicit expressions for the process functions having the highest patient-to-patient variation in their estimated values. Small variations from patient to patient for several parameters of the new model collectively accounted for the large variations observed in the steady-state viral burden. The novel model remains in full agreement with previous models and data.

MeSH Terms
HIV Infections/complications,virology HIV-1/isolation & purification,pathogenicity Humans Models, Biological Viral Load Viremia/complications,virology
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Müller V
Department of Plant Taxonomy and Ecology, Eötvös Lorand University, Budapest, Hungary.
Marée A F
De Boer R J
References (40)
40 references, click to expand
  1. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.
    Nature. 1995 Jan 12;373(6510):123-6 PMID: 7816094
  2. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors.
    J Virol. 1995 Sep;69(9):5838-42 PMID: 7637030
  3. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.
    Science. 1995 Nov 10;270(5238):988-91 PMID: 7481804
  4. Population dynamics of immune responses to persistent viruses.
    Science. 1996 Apr 5;272(5258):74-9 PMID: 8600540
  5. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.
    Science. 1996 Mar 15;271(5255):1582-6 PMID: 8599114
  6. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.
    Science. 1996 May 24;272(5265):1167-70 PMID: 8638160
  7. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome.
    AIDS. 1996 Feb;10(2):167-73 PMID: 8838704
  8. Quantitative image analysis of HIV-1 infection in lymphoid tissue.
    Science. 1996 Nov 8;274(5289):985-9 PMID: 8875941
  9. Clinical data sets of human immunodeficiency virus type 1 reverse transcriptase-resistant mutants explained by a mathematical model.
    J Virol. 1997 Jan;71(1):161-8 PMID: 8985335
  10. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.
    Nat Med. 1997 Feb;3(2):205-11 PMID: 9018240
  11. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS.
    Nat Med. 1997 Feb;3(2):212-7 PMID: 9018241
  12. Human immunodeficiency virus drug therapy and virus load.
    J Virol. 1997 Apr;71(4):3275-8 PMID: 9060694
  13. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection.
    Science. 1997 May 9;276(5314):960-4 PMID: 9139661
  14. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
    Nature. 1997 May 8;387(6629):183-8 PMID: 9144289
  15. Virus dynamics and drug therapy.
    Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6971-6 PMID: 9192676
  16. Target cell limited and immune control models of HIV infection: a comparison.
    J Theor Biol. 1998 Feb 7;190(3):201-14 PMID: 9514649
  17. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.
    Science. 1998 Mar 27;279(5359):2103-6 PMID: 9516110
  18. Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy.
    Nat Med. 1998 Jul;4(7):794-801 PMID: 9662370
  19. Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen.
    AIDS. 1998 Aug 20;12(12):1483-90 PMID: 9727569
  20. Target cell availability and the successful suppression of HIV by hydroxyurea and didanosine.
    AIDS. 1998 Sep 10;12(13):1567-70 PMID: 9764774
  21. Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection.
    J Infect Dis. 1998 Nov;178(5):1279-87 PMID: 9780247
  22. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans.
    Nat Med. 1999 Jan;5(1):83-9 PMID: 9883844
  23. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy.
    J Virol. 1999 Jan;73(1):797-800 PMID: 9847391
  24. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.
    Science. 1999 Feb 5;283(5403):857-60 PMID: 9933172
  25. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.
    J Exp Med. 1999 Mar 15;189(6):991-8 PMID: 10075982
  26. Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA.
    J Exp Med. 1999 May 17;189(10):1545-54 PMID: 10330433
  27. Improved estimates for HIV-1 clearance rate and intracellular delay.
    AIDS. 1999 Jul 30;13(11):1415-7 PMID: 10449298
  28. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis.
    Lancet. 1999 Nov 20;354(9192):1782-5 PMID: 10577640
  29. Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes.
    Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3382-7 PMID: 10737796
  30. Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection.
    J Virol. 2000 Jul;74(13):5747-53 PMID: 10846052
  31. Paradox of enrichment: destabilization of exploitation ecosystems in ecological time.
    Science. 1971 Jan 29;171(3969):385-7 PMID: 5538935
  32. Population dynamics of HIV within an individual after treatment with zidovudine.
    AIDS. 1991 May;5(5):485-9 PMID: 1677807
  33. Competition between zidovudine-sensitive and zidovudine-resistant strains of HIV.
    AIDS. 1992 Jan;6(1):71-9 PMID: 1543568
  34. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.
    Nature. 1993 Mar 25;362(6418):355-8 PMID: 8455722
  35. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.
    Nature. 1993 Mar 25;362(6418):359-62 PMID: 8096068
  36. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.
    Science. 1993 Mar 19;259(5102):1749-54 PMID: 8096089
  37. How does HIV cause AIDS?
    Science. 1993 May 28;260(5112):1273-9 PMID: 8493571
  38. Multifactorial nature of human immunodeficiency virus disease: implications for therapy.
    Science. 1993 Nov 12;262(5136):1011-8 PMID: 8235617
  39. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
    J Virol. 1994 Sep;68(9):6103-10 PMID: 8057491
  40. Viral dynamics in human immunodeficiency virus type 1 infection.
    Nature. 1995 Jan 12;373(6510):117-22 PMID: 7529365
Article Info
Journal
Proceedings. Biological sciences
Abbr.
Proc Biol Sci
ISSN
0962-8452
Published
2001-02-07
Pages
235-42
Language
English
Region
England
NLM ID
101245157
PMCID
PMC1088597
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com